If the information provided is confidential within the meaning of Article 7(5) of Regulation (EU) No 511/2014, please provide it nonetheless, tick the respective box and provide the justification for confidentiality at the end of this Annex.
If you marked as confidential essential information (such as about the genetic resources or traditional knowledge associated with genetic resources, access place, form of utilisation) without which the record would not be published on the website of the ABS Clearing House, this information will not be shared with the Clearing House but it may be passed on directly to the competent authorities of the provider country.
If the utilisation has involved more than one genetic resource or any traditional knowledge associated with genetic resources, please provide relevant information for each genetic resource or any traditional knowledge utilised.
I declare that I have fulfilled the obligations under Article 4 of Regulation (EU) No 511/2014. I am making this declaration for the utilisation of:
Please tick the appropriate box or boxes:
☐ Genetic resources
☐ Traditional knowledge associated with genetic resources
Name of the product or description of the result of the utilisation [‘Result of the utilisation of genetic resources and traditional knowledge associated with genetic resources’ means products, precursors or predecessors to a product, as well as parts of products to be incorporated into a final product, blueprints or designs, based on which manufacturing and production could be carried out without further utilisation of the genetic resource and traditional knowledge associated with genetic resources.] or description of the outcome of the utilisation [Where the utilisation in the Union has ended and its outcome is sold or transferred in any other way to a natural or legal person outside the Union.]:
☐ Confidential
Contact details of the user:
Name:
Address:
E-mail:
Telephone:
Website, where available:
The declaration is made on the occasion of the following event:
Please tick the appropriate box:
☐ (a) market approval or authorisation is sought for a product developed via the utilisation of genetic resources and traditional knowledge associated with genetic resources;
☐ (b) a notification required prior to placing for the first time on the Union market is made for a product developed via the utilisation of genetic resources and traditional knowledge associated with genetic resources;
☐ (c) placing for the first time on the Union market a product developed via the utilisation of genetic resources and traditional knowledge associated with genetic resources, for which no market approval, authorisation or notification is required;
☐ (d) the result of the utilisation is sold or transferred in any other way to a natural or legal person within the Union in order for that person to carry out one of the activities referred to in points (a), (b) and (c);
☐ (e) the utilisation has ended in the Union and its outcome is sold or transferred in any other way to a natural or legal person outside the Union.
Information on exercise of due diligence:
☐ An internationally recognised certificate of compliance (i) was issued for my (entity's) access or (ii) covers the terms of this access to the genetic resource(s) and traditional knowledge associated with genetic resources.
Where this box is ticked, please indicate the unique identifier of the internationally recognised certificate of compliance:
Please go to point 2 of Part B.
Where the box in point (a) has not been ticked, please fill in the following information:
Place of access:
☐ Confidential
Description of the genetic resource or traditional knowledge associated with genetic resources utilised, or unique identifier(s), where available:
☐ Confidential
Date of access:
☐ Confidential
Identifier of access permit or its equivalent [Evidence of the decision to grant prior informed consent or approval for access to genetic resources and traditional knowledge associated with genetic resources.], where available:
☐ Confidential
Person or entity who granted prior informed consent:
☐ Confidential
Person or entity to whom the prior informed consent was granted:
☐ Confidential
Is the utilisation of genetic resources and traditional knowledge associated with genetic resources subject to mutually agreed terms?
Yes ☐ | No ☐
☐ Confidential
Please go to point 1 of Part B.
Information on exercise of due diligence:
Direct source of the genetic resource and the traditional knowledge associated with genetic resources:
Are there any restrictions in the mutually agreed terms limiting the possible utilisation of the genetic resource(s) or the traditional knowledge associated with genetic resources, e.g. allowing for non-commercial utilisation only?
Yes ☐ | No ☐ | Not applicable ☐
Have there been rights and obligations agreed regarding subsequent applications and commercialisation in the mutually agreed terms?
Yes ☐ | No ☐ | Not applicable ☐
If the genetic resource(s) was(were) obtained from a registered collection, please provide the registration code of the collection:
If you are implementing a best practice recognised under Article 8 of Regulation (EU) No 511/2014, please provide the registration number:
Which category best describes your product (optional)?
☐ (a) cosmetics
☐ (b) medicinal products
☐ (c) food and beverage
☐ (d) biological control
☐ (e) plant breeding
☐ (f) animal breeding
☐ (g) other, please specify:
Member State(s) in which the utilisation of genetic resources and traditional knowledge associated with genetic resources has taken place:
Member State(s) in which the product is to be placed on the market, following the procedure for approval, authorisation or notification referred to in Article 6(2)(a) and (b) of Commission Regulation (EU) 2015/1866 or placed on the market in accordance with Article 6(2)(c) of that Regulation:
If you have declared that some information is confidential within the meaning of Article 7(5) of Regulation (EU) No 511/2014, please state the reasons for each piece of information for which you have declared that confidentiality applies:
Date:
Place:
Signature [Signature of the person legally responsible for the stage of final development of a product.]: